Presentation of "Lung Cancer: An Overview & Discussion of Minimally Invasive Surgical Therapy," by Dr. Conrad Vial, Director of Cardiothoracic Surgery, Mills-Peninsula Health Services.
Call Girls Service Bellary Road Just Call 7001305949 Enjoy College Girls Service
Lung Cancer: An Overview & Discussion of Minimally Invasive Surgical Therapy
1. Lung Cancer: an overview & discussion of minimally invasive surgical therapy Conrad Massimo Vial, MD Director of Cardiothoracic Surgery Mills Peninsula Health System
2.
3.
4.
5.
6.
7.
8. Tumor T1 T2 T3 T4 Nodes N0 N1 N2 N3 IA IB IIB IIIB Stage IV = M1 Stage IIIB and IV generally unresectable Lung Cancer IIIB IIIB IIIB IIIB IIIA IIIA IIIA IIIB IIA IIB IIIA IIIB
9. 5-yr survival for treated NSCLC according to surg-path state: Stage I: ≈ 70% Stage II: ≈ 50% Stage III: ≈ 20%
10. Minimally Invasive Lung Cancer Operations Video Assisted Thoracoscopic (VATS) Lobectomy & Lung Sparing Operations
26. Diversity & Complexity of Major Thoracic Lung Operations Bronchoplasty and/or Sleeve Resection n=15 Thoracoscopic Lobectomy n=107
27. STS NATIONAL DATABASE Influence of Functional Score in Resections for Lung Cancer ZUBROD SCORE MORTALITY LOS > 14 DAYS COMPLICATIONS 0 1.3% 4.8% 32% 1 1.8% 6.8% 35% 2 3.5% 12% 41% 3 7% 14% 46% 4 16% 21% 51%
28. STS NATIONAL DATABASE Influence of FEV 1 in Resections for Lung Cancer Preop FEV 1 MORTALITY LOS > 14 DAYS COMPLICATIONS > 80% pred 1.1% 4% 30% 61-79% pred 2% 8% 39% < 60% pred 2% 9% 41%
29. Diversity & Complexity of Major Thoracic Operations for Lung Ca Bronchoplasty and/or Sleeve Resection n=15 Thoracoscopic Lobectomy n=107
30. CRUDE Benchmarking “Best Case” vs Non-risk adjusted Best Case Lung Ca Resection STS Scenario Mortality LOS > 14 days Complications Preop FEV 1 > 80% pred & Zubrod Score 0 ~1.2% ~4% ~30%